Haekyung Jeon-Slaughter

Dr. Haekyung Jeon-Slaughter

UT Southwestern Medical Center, Dallas, TX 75390, USA
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
Haekyung Jeon-SlaughterHaekyung Jeon-Slaughter
Haekyung Jeon-Slaughter
XCXiaofei Chen
Xiaofei Chen
STShirling Tsai
Shirling Tsai
BRBala Ramanan
Bala Ramanan
RERamin Ebrahimi
Ramin Ebrahimi
Background: The current American College of Cardiology/American Heart Association women cardiovascular disease (CVD) risk score suboptimally estimates CVD risk for young and minority women in the military. The current study developed an internally validated CVD risk score for women military service members and veterans using the Veterans Affairs (VA) national electronic health records data. Methods and Results: The study cohort included 69 574 White, Black, and Hispanic women service members and veterans aged 30 to 79 years in 2007 treated in the VA Health Care System between January 1, 2007 and December 31, 2017 (henceforth, VA women). Stratified by race and ethnicity, the new VA women CVD risk model estimated risk coefficients and 10‐year CVD risk using a time‐variant covariate Cox model. Harrell C‐statistics, calibration plots, and net classification index were used to assess accuracy and prognostic performance of the new VA women CVD risk model. The new internally validated VA women CVD risk score performed better in predicting VA women 10‐year atherosclerosis cardiovascular disease risk than the pooled cohort American College of Cardiology/American Heart Association risk score in both accuracy (White Harrell C‐statistics, 70% versus 61%; Black, 68% versus 63%) and prognostic performance (White net classification index, 0.31; 95% CI, 0.26–0.33; Black net classification index, 0.06; 95% CI, 0.03–0.09). Conclusions: The proposed VA women CVD risk score improves accuracy of the existing American College of Cardiology/American Heart Association CVD risk assessment tool in predicting long‐term CVD risk for VA women, particularly in young and racial/ethnic minority women.

1 February 2015 in Journal of Substance Abuse Treatment
Verified
Journal Article
Closed access
CFColleen S. Fagan
Colleen S. Fagan
TCThomas J. Carmody
Thomas J. Carmody
SMShawn M. McClintock
Shawn M. McClintock
ASAlina Suris
Alina Suris
ANAlyson Nakamura
Alyson Nakamura
EBE. Sherwood Brown
E. Sherwood Brown

EWErum Z. Whyne
Erum Z. Whyne
JWJihun Woo
Jihun Woo
Haekyung Jeon-SlaughterHaekyung Jeon-Slaughter
Haekyung Jeon-Slaughter
Subjective wellbeing may predict future health conditions, and lower self-rated physical health (SRH) is associated with the presence of chronic conditions, such as cardiovascular disease (CVD). This study examines whether subjective wellbeing and SRH predict long-term CVD conditions for women using the Midlife in the United States study. The study cohort includes 1716 women participants who completed waves 1 (1995–1996), 2 (2004–2006), and 3 (2013–2014). Data on demographics, chronic conditions of diabetes and CVD, subjective wellbeing (life satisfaction, positive affect, and negative affect), and SRH were collected repeatedly at each wave. Multiple logistic regressions were conducted to test whether subjective wellbeing was associated with a lifetime CVD risk. Greater life satisfaction was significantly associated with a lower risk of CVD at 10 years (odds ratio (OR): 0.83; 95% confidence interval (CI): 0.74–0.95) and 19 years (OR: 0.83; 95% CI: 0.74–0.93), while positive and negative affects were not significantly associated. Additionally, better physical SRH significantly lowered odds of having cardiovascular conditions at both 10 years (OR: 0.79; 95% CI 0.68–0.92) and 19 years (OR 0.74; 95% CI: 0.64–0.86). Measures of life satisfaction and SRH can be used as additional CVD screening tools.

2 January 2015 in Teaching and Learning in Medicine
Verified
Journal Article
Closed access
Phebe TuckerPhebe Tucker
Phebe Tucker
Haekyung Jeon-SlaughterHaekyung Jeon-Slaughter
Haekyung Jeon-Slaughter
USUgur Sener
Ugur Sener
MAMegan Arvidson
Megan Arvidson
AKAndrey Khalafian
Andrey Khalafian
We explored the theory that measures of medical students' well-being and stress from different types of preclinical curricula are linked with performance on standardized assessment. Self-reported stress and quality of life among sophomore medical students having different types of preclinical curricula will vary in their relationships to USMLE Step 1 scores. Voluntary surveys in 2010 and 2011 compared self-reported stress, physical and mental health, and quality of life with Step 1 scores for beginning sophomore students in the final year of a traditional, discipline-based curriculum and the 1st year of a revised, systems-based curriculum with changed grading system. Wilcoxon rank sum tests and Spearman rank correlations were used to analyze data, significant at p <.05. New curriculum students reported worse physical health, subjective feelings, leisure activities, social relationships and morale, and more depressive symptoms and life stress than traditional curriculum students. However, among curriculum-related stressors, few differences emerged; revised curriculum sophomores reported less stress working with real and standardized patients than traditional students. There were no class differences in respondents' Step 1 scores. Among emotional and physical health measures, only feelings of morale correlated negatively with Step 1 performance. Revised curriculum students' Step 1 scores correlated negatively with stress from difficulty of coursework. Although revised curriculum students reported worse quality of life, general stress, and health and less stress from patient interactions than traditional students, few measures were associated with performance differences on Step 1. Moreover, curriculum type did not appear to either hinder or help students' Step 1 performance. To identify and help students at risk for academic problems, future assessments of correlates of Step 1 performance should be repeated after the new curriculum is well established, relating them also to performance on other standardized assessments of communication skills, professionalism, and later clinical evaluations in clerkships or internships.

19 April 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
STShirling Tsai
Shirling Tsai
HNHang Nguyen
Hang Nguyen
RERamin Ebrahimi
Ramin Ebrahimi
MBMonica R. Barbosa
Monica R. Barbosa
BRBala Ramanan
Bala Ramanan
Haekyung Jeon-SlaughterHaekyung Jeon-Slaughter
Haekyung Jeon-Slaughter
The burden of COVID-19 has been noted to be disproportionately greater in minority women, a population that is nevertheless still understudied in COVID-19 research. We conducted an observational study to examine COVID-19-associated mortality and cardiovascular disease outcomes after testing (henceforth index) among a racially diverse adult women veteran population. We assembled a retrospective cohort from a Veterans Affairs (VA) national COVID-19 shared data repository, collected between February and August 2020. A case was defined as a woman veteran who tested positive for SARS-COV-2, and a control as a woman veteran who tested negative. We used Kaplan–Meier curves and the Cox proportional hazards model to examine the distribution of time to death and the effects of baseline predictors on mortality risk. We used generalized linear models to examine 60-day cardiovascular disease outcomes. Covariates studied included age, body mass index (BMI), and active smoking status at index, and pre-existing conditions of diabetes, chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), and a history of treatment with antiplatelet or anti-thrombotic drug at any time in the 2 years prior to the index date. Women veterans who tested positive for SARS-CoV-2 had 4 times higher mortality risk than women veterans who tested negative (Hazard Ratio 3.8, 95% Confidence Interval CI 2.92 to 4.89) but had lower risk of cardiovascular events (Odds Ratio OR 0.78, 95% CI 0.66 to 0.92) and developing new heart disease conditions within 60 days (OR 0.67, 95% CI 0.58 to 0.77). Older age, obesity (BMI > 30), and prior CVD and COPD conditions were positively associated with increased mortality in 60 days. Despite a higher infection rate among minority women veterans, there was no significant race difference in mortality, cardiovascular events, or onset of heart disease. SARS-CoV-2 infection increased short-term mortality risk among women veterans similarly across race groups. However, there was no evidence of increased cardiovascular disease incidence in 60 days. A longer follow-up of women veterans who tested positive is warranted.

16 June 2020 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
XCXiaofei Chen
Xiaofei Chen
BRBala Ramanan
Bala Ramanan
STShirling Tsai
Shirling Tsai
Haekyung Jeon-SlaughterHaekyung Jeon-Slaughter
Haekyung Jeon-Slaughter
Background: Atherosclerotic cardiovascular disease ( ASCVD ) is the third leading cause of death in women service members and veterans. This study assessed 10‐year ASCVD risk in women service members and veterans using their own electronic health record data extracted from Veterans Affairs ( VA ) national Corporate Data Warehouse database. Methods and Results: We retrospectively followed 69 574 VA women, aged 30 to 79 years, from 2007 to 2017. Of these, 52% were whites (n=36 172), 42% were blacks (n=29 232), and 6% were Hispanics (n=4171). Risk factors and ASCVD events (nonfatal myocardial infarction, nonfatal stroke, and cardiac deaths) were identified using diagnostic and procedural codes from electronic health records. Then, within the same construct of the current American College of Cardiology/American Heart Association 10‐year ASCVD risk assessment models for women, coefficients for risks factors were recalculated using the VA national electronic health record data, stratified by race (hereafter, VA women model). Our study found a curvilinear association of aging with increased risk of 10‐year ASCVD event in VA women starting at ages as young as 30 years across all race groups. The VA women model performance in predicting ASCVD events at 10 years was mixed‐moderate in discrimination (C statistics, 0.61–0.64) but good in accuracy, as demonstrated by calibration plots approximating a 45° line. Conclusions: The study finding, a curvilinear association of aging with increased ASCVD risk in VA women across all races, demonstrates the need for cardiovascular risk screening of younger VA women, aged <45 years.